Journal Article Accepted manuscript Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: The ULTIMATE-DAPT trial Get access Pascal Vranckx, MD MBA PhD, Pascal Vranckx, MD MBA PhD Department of Cardiology and Intensive Care, Jessa Ziekenhuis Hasselt, Hasselt, BelgiumFaculty of Medicine and Life Sciences, University of Hasselt, Hasselt, Belgium Search for other works by this author on: Oxford Academic Google Scholar Marco Valgimigli, MD PhD Marco Valgimigli, MD PhD Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), CH-6900, Lugano, SwitzerlandDepartment of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland Corresponding author: Professor Marco Valgimigli, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC). Via Tesserete 46, CH-6900 Lugano, Switzerland, Tel: +41 91 811 53 47, Fax: +41 91 811 30 34, Email: marco.valgimigli@eoc.ch, Twitter: @vlgmrc https://orcid.org/0000-0002-4353-7110 Search for other works by this author on: Oxford Academic Google Scholar European Heart Journal. Acute Cardiovascular Care, zuae048, https://doi.org/10.1093/ehjacc/zuae048 Published: 10 April 2024 Article history Received: 09 April 2024 Accepted: 10 April 2024 Published: 10 April 2024
No takes yet. Share an insight, caveat, or question.
Vranckx et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: